L.WardD
WEIGHTWATCHERS CEO SIMA SISTANI OUT IN ABRUPT EXIT, EMBRACED WEIGHT LOSS DRUGS McGowan agreed that patients will need to seek alternative treatments, though he said "it's worth noting that this has never been a viable long-term solution, knowing that supply lines for semaglutide and tirzepatide would eventually be restored." Patients who may lose access can look into options including switching to the brand-name, Zepbound, changing medication class entirely or seeking a procedural or surgical option if that fits their overall goals, according to McGowan
A landmark human trial published in Nature Medicine by Depommier and colleagues (2019) showed that pasteurized Akkermansia supplementation improved insulin sensitivity, reduced total cholesterol, and decreased body weight slightly in overweight and obese individuals over a three-month period
Ongoing support is available through a dedicated care team and secure messaging
Optimization experiments, resulting in improvements of the assays sensitivity, included varying the fetal calf serum content in the assay medium, the concentration of pre-incubation drug needed for cell stimulation, and the concentration of PEG used for sample pre-treatment precipitation of the ADAs